Cryo-Cell International, Inc. Common Stock — Bilan trimestriel (NYSE:CCEL) | MetaTrader

Afficher le graphique complet Full chart

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Nouvelles

NYSE accepte le plan de Cryo-Cell pour retrouver sa conformité boursière

Cryo-Cell obtient le renouvellement de son accréditation FACT jusqu’en 2029

Le BPA de CryoCell International a dépassé les attentes de 0,10$, le CA a surpassé les prévisions

Cryo-Cell reçoit un avis de non-conformité du NYSE American

Cryo-Cell receives NYSE American non-compliance notice

Cryo-Cell International modifie son accord de crédit, ajuste les conditions et l’échéance

Cryo-Cell International amends credit agreement, adjusts loan terms and maturity

Le BPA de CryoCell International a dépassé les attentes de 0,13$, le CA en dessous des prévisions

CryoCell International earnings beat by $0.13, revenue fell short of estimates

Cryo-Cell suspends quarterly dividend amid profitability concerns

CryoCell International earnings beat by $0.01, revenue fell short of estimates